CALS Patient Activated Learning System (PALS)

February 9, 2024 updated by: Cornell University

Can the Digital Patient Activated Learning System Increase Racial Minority Engagement With Health Information? A Multi-Site Pilot Examination in New York State

The overall goal in this line of inquiry is to test whether the Patient Activated Learning System (PALS) is effective in reducing disparities in access to reliable, easily understood health information, and whether this increased understanding has downstream consequences such as increases in trust in the medical system and self-management behaviors.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Participants will view, in randomized order, PALS or WebMD content on hypertension and on high cholesterol. This study will test knowledge uptake across topics as well as attitudes toward and trust in the information and information providers.

Study Type

Interventional

Enrollment (Actual)

232

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • New York, New York, United States, 10021
        • Weill Cornell Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patient ≥ 18 years of age.
  • Self-reported hypertension diagnosis.
  • English speaking
  • Passing the cognition screener
  • Able to read in English
  • Patient at designated recruitment clinics

Exclusion Criteria:

  • Non-English speakers
  • Not having self-identified as having hypertension
  • Inability to read in English
  • Being younger than 18
  • Not passing the screener
  • Not being a patient on the participating clinics

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Arm 1 - Educational Platform, PALS
The Patient Activated Learning System is a free, health education platform written bu trusted MDs.
Other: The Patient Activated Learning System (PALS)
Randomization into PALS arm.
Other: Arm 2 - WebMD
WebMD is a widely used educational platform for health information.
Other: WebMD
Randomization into WebMD arm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge
Time Frame: Day 1, Immediately after reading article
as measured by assessment questions on the nutrition information provided
Day 1, Immediately after reading article
Trust in eHealth
Time Frame: Day 1, Immediately after reading article
as measured by e-Health Impact Questionnaire by Kelly et al. on a 5-point likert scale where one is strongly disagree and 5 is strongly agree
Day 1, Immediately after reading article
E-health usability
Time Frame: Day 1, Immediately after reading article
as measured by e-Health Impact Questionnaire scale by Harris et al. on a 5-point likert scale where one is strongly disagree and 5 is strongly agree
Day 1, Immediately after reading article
Physician trust
Time Frame: Day 1, Immediately after reading article
as measured by assessment questions from Wake Forest Physician Trust Scale on a 5-point likert scale where one is strongly disagree and 5 is strongly agree
Day 1, Immediately after reading article

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cornell University

Investigators

  • Principal Investigator: Neil Lewis, PhD, Cornell University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 18, 2020

Primary Completion (Actual)

November 1, 2023

Study Completion (Actual)

November 1, 2023

Study Registration Dates

First Submitted

December 23, 2019

First Submitted That Met QC Criteria

December 24, 2019

First Posted (Actual)

December 26, 2019

Study Record Updates

Last Update Posted (Estimated)

February 13, 2024

Last Update Submitted That Met QC Criteria

February 9, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 19-08020714

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Communication

Clinical Trials on The Patient Activated Learning System (PALS)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe